Fig. 5.
Residual beta cell function at diabetes onset (a) and at follow-up (b) in CHI patients with diabetes compared to patients with T1DM. C-peptide secretion; n = 11 (diabetes onset) and 8 (follow-up) CHI patients with diabetes, and n = 13,746 (diabetes onset) and 3497 (follow-up) patients with T1DM. All values are means. Significance determined by p < 0.05 using χ2-test